Drug Shortage Report for ETOPOSIDE INJECTION USP

Last updated on 2017-08-02 History
Report ID 2567
Drug Identification Number 02380935
Brand name ETOPOSIDE INJECTION USP
Common or Proper name ETOPOSIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ETOPOSIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10ML
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-14
Estimated end date 2017-07-28
Actual end date 2017-07-28
Shortage status Resolved
Updated date 2017-08-02
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2017-08-02 French Compare
v10 2017-08-02 English Compare
v9 2017-07-18 French Compare
v8 2017-07-18 English Compare
v7 2017-05-17 French Compare
v6 2017-05-17 English Compare
v5 2017-04-11 French Compare
v4 2017-04-11 English Compare
v3 2017-03-15 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 11 of 11